The Experts in Animal Health

printer friendly

Brakke Consulting’s
Animal Health News & Notes for March 10, 2017

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
Pain Management Products report
Strategic planning services
earnings news
other news
Animal Clinical Investigation
Ascendis Health
Blue Buffalo
Brookside Agra
Ethos Veterinary Health
Evanger’s Dog & Cat Food
Gambol Pet Group
H&C Animal Health
Integrated Animal Health
Kane Biotech
Royal DSM


Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
– overview of acute and chronic pain in small animals
– review of new products, including Galliprant, Nocita, and Onsior for Dogs
– estimates of US sales and prices of leading products
– pain management products in development
– review of nutritional supplements used for chronic pain
– review of therapeutic diets for joint care
– 2017 survey of 300 small animal veterinarians regarding use of pain management products

Pain Management Products for Dogs and Cats 2017 can be purchased for $4,995 if ordered by March 31, 2017, and $5,500 thereafter. The report will be completed in April. Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at 972-243-4033, or email

• Krka reported results for the full year 2016.  The firm’s animal health revenues were EUR 62.8 million ($66.1 million) in 2016, an increase of 20% compared to the prior year. Animal health represents 5.3% of Krka’s overall sales, up from 4.5% in 2015. (Animal Pharm)

The KC Animal Health Corridor is now accepting applications to present at the 2017 KC Animal Health Investment Forum on August 29 in Kansas City, Missouri.

Now in its ninth year, the Forum is one of the only opportunities in the world for early-stage companies in the animal health sector to present their vision, business plan and technology to potential investors.

The selection committee will consider companies that meet the following criteria:
– Seeking $500,000 – $20 million in funding
– Revenue projections of $20 million within 5-7 years

Applications are due on April 14. To apply, go to

For more information, contact Kimberly Young at


• Zoetis announced that Pet-Tabs and Pet-Cal for dogs and cats are returning to pet specialty retailers, exclusively available through H&C Animal Health. (Pet Age)

• Merck Animal Health announced the FDA has approved Revalor-XR (trenbolone acetate and estradiol) for over-the-counter sale.  Revalor-XR is an extended-release subcutaneous implant for beef steers and heifers fed in confinement for slaughter. (Animal Pharm)

• Bimeda Inc. announced the renaming of the Altresyn (altrenogest) product for horses to OvaMed. Altresyn was recently acquired from Ceva Animal Health as part of Bimeda’s strategic expansion into the equine segment.  (company press release)

• IVAOES announced the launch of Rapanofol (propofol injectable emulstion) anesthetic for the veterinary market. (WVC)

• Kane Biotech announced an exclusive license with Dechra Veterinary Products to market its StrixNB and DispersinB oral care and dermatology products in the North American veterinary market. (company press release)

• Blue Buffalo announced it has issued a voluntary market withdrawal of 17 varieties of BLUE Divine Delights 3.5-ounce cups and BLUE Wilderness Trail Trays 3.5-ounce cups. This withdrawal is being executed due to a quality issue with the foil seal on the top of the cup. No other Blue Buffalo products are impacted by this issue. Blue Buffalo is not aware of any dogs becoming ill from these products. (PetFoodIndustry)

• Evanger’s Dog & Cat Food announced it is expanding its recall of Hunk of Beef and is also recalling Evanger’s Braised Beef and Against the Grain’s Pulled Beef Products due to potential adulteration with pentobarbital. Consumers who notice these symptoms in their pets should consult their veterinarian. (FDA)

• Brookside Agra announced the launch of Calf-Rescue oral nutritional supplement for dairy and beef calves. Calf-Rescue contains select vitamins and a stabilized source of direct-fed microbials (probiotics) to maintain a healthy, natural appetite, digestion and immune system. (company press release)

• Midmark Animal Health announced the launch of the Thermofield hyperthermia deep tissue heating system. The system uses microwaves to treat cancerous superficial tumors by combining heat with standard modalities like chemotherapy and radiotherapy to make them more effective. (company press release)

• Royal DSM and Evonik announced they will establish a joint venture for omega-3 fatty acid products from natural marine algae for animal nutrition. (Feedstuffs)

• Phosphagenics Ltd Co and Integrated Animal Health Pty Ltd announced that they have mutually agreed to cease all and any of their licenses. (Reuters)

• BAMPZ, LLC announced the acquisition of the assets and intellectual property of H2O4K9 dog water bottles and NEOSLING brands. Financial terms were not disclosed. (Pet Age)

• Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) announced a strategic alliance to establish a multi-specialty clinical trial network comprised of a geographically diverse, nationwide collection of Ethos veterinary hospitals. (company press release)

• AFRICA  Cipla announced an agreement to divest two African subsidiaries, Cipla Agrimed and Cipla Vet Proprietary, to Ascendis Health for ZAR375 million ($29 million). (Animal Pharm)

• CHINA  Global investment firm KKR announced an unspecified investment in China-based Gambol Pet Group to expand the Company’s production capacity in key markets including China, Thailand, countries in Europe, and the US, where it is currently the largest private-label provider of pet treats to Walmart. (Pets International)
MARCH 5 – 9, 2017

Veterinarians, technicians, students, exhibitors and others attended the Western Veterinary Conference this week in Las Vegas. The conference offered over 1,000 CE credit hours to choose from, including traditional lectures, workshops, hands-on laboratories, and more.

• US – AVIAN INFLUENZA  A commercial chicken breeding facility with about 73,500 chickens in south-central Tennessee reported an outbreak of the H7N9 strain of Highly Pathogenic Avian Influenza. The facility and about 30 other poultry farms within about a six-mile radius of the site are under quarantine. (AVMA SmartBrief, AP)

• US – BOVINE TUBERCULOSIS  A South Dakota ranch is under quarantine after three cows originating there were found to be infected with bovine tuberculosis. All fenceline neighbors are under quarantine at this time, too. A total of approximately 10,000 head of cattle are quarantined. South Dakota retains its TB–free designation. (AVMA –


Brakke Consulting is an excellent resource for your company’s strategic planning. Some of the services we offer include:
 – Reviewing revenue estimates and success probability of your product pipeline
 – Reviewing the timing of various new product introductions and estimate the impact of various scenarios
 – Benchmarking various functions against company competitors in the larger markets

Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company’s future endeavors.

Contact us for professional assistance in any of these areas.

What an exciting week at the Western Veterinary Congress! The meeting was well attended and we appreciate all the various interfaces we had during the meeting with current and future clients. 

It appears that the industry is off to a reasonable start in 2017.  There were new product and services launches from a number of companies at WVC. While these meetings are often dominated by the larger companies, we were pleased to see the increased visibility from several smaller and medium-sized firms.  Our newsletter today also covers agreements and transactions from companies that are not in the news frequently.  We view this as positive for the industry as consolidation of larger firms continues at a rapid pace.

Have a great weekend!

Ron Brakke

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)